Research News & Publications

How MAGE-A11 gene drives cancer revealed

01/21/2020

Results show a gene that drives cancer by promoting alternative polyadenylation
Partnership with China prompts change in care for high-risk type of leukemia

01/16/2020

Findings from a collaborative clinical trial have generated key insights into how targeted therapy should be used to treat leukemia driven by the Philadelphia chromosome.
St. Jude hematologist Akshay Sharma receives ASH 2020 Scholar Award

01/10/2020

Akshay Sharma, MBBS, of St. Jude is the recipient of a 2020 Scholar Award from the American Society of Hematology (ASH).
St. Jude announces plans to build new shared resource center

01/09/2020

The new Shared Resource Center will enhance the capabilities of St. Jude researchers looking to discover new treatments for pediatric cancer.
Comprehensive protein analysis offers clues to progression of Alzheimer’s disease

01/08/2020

St. Jude Children’s Research Hospital scientists have identified proteins that play critical roles in Alzheimer’s disease and provide a framework for developing new diagnostic and treatment strategies.
Breaking the dogma: Key cell death regulator has more than one way to get the job done

12/23/2019

Scientists explain how cell death caused from this protein could lead to drug treatments to prevent the inflammatory, cell-killing response of septic shock.
Models for Wilms tumor research

12/20/2019

Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor.
Diagnostic test helps find bloodstream infections before they appear

12/19/2019

Researchers at St. Jude Children’s Research Hospital are testing a game-changing technique for predicting infection in patients with weakened immune systems.
Research reveals how muscles talk to the brain to regulate feeding behavior

12/12/2019

A study from St. Jude Children’s Research Hospital sheds light on the mechanisms governing feeding behavior in fruit flies and how skeletal muscle communicates energy needs to the brain.
Researchers reprogram T cells to improve cancer immunotherapy

12/11/2019

Read about a molecule that researchers are targeting in hopes of improving cancer immunotherapy, including CAR-T cell therapy, against solid tumors as well as leukemia.